- Prognostic value of serum osteopontin in hepatocellular carcinoma patients treated with transarterial chemoembolization
-
Kim SH, Chung YH, Yang SH, Kim JA, Jang MK, Kim SE, Lee D, Lee SH, Lee D, Kim KM, Lim YS, Lee HC, Lee YS, Suh DJ
- KMID: 1374960
- Korean J Hepatol.
- 2009 Sep;15(3):320-330.
- doi: 10.3350/kjhep.2009.15.3.320
BACKGROUND/AIMS: Osteopontin (OPN) is overexpressed in hepatocellular carcinoma (HCC) with postoperative recurrence or extrahepatic metastasis. However, its prognostic value in patients treated with transarterial chemoembolization (TACE) is unclear. We investigated... -
- CITED
-
- Close
- SHARE
-
- Close
